News
BIO Digital: You Don’t Want to Miss It!
Next week BIO Digital takes place and you don’t want to miss it! The event includes trending and inspiring key note sessions like ‘Breaking Barriers in Science’ featuring Dr. Jennifer Doudna, Nobel Laureate and CRISPR pioneer and ‘Breaking Barriers in Vaccine Development’ with Dr. Albert Bourla, CEO of Pfizer, One-on-One partnering with potential partners, company pitches at innovation stages, and many more.
Hooghangend Investeringsfruit Rijp om te Plukken
De basis van ons investeringsklimaat is op orde, maar in bepaalde sectoren is nog een wereld te winnen. Dat is de conclusie uit een recent onderzoek van Dialogic naar het Nederlandse investeringsklimaat. Voor de LSH-sector adviseert Dialogic het financieringslandschap te verbeteren, complexe wet- en regelgeving weg te nemen en valorisatie te versoepelen.
Bringing Perspectives Together and Providing Collective Guidance to the Innovator
In 2020 Health~Holland and Health Innovation Netherlands (HI-NL) decided to work together and advise consortia funded through the Match Call programme to make use of the HI-NL Round Table service. This is particularly encouraged if the innovation studied will request CE marking during or within two years of the project. The shared goal of Health~Holland and HI-NL is to set new innovations on the right path from the outset.
Venture Challenge Summer 2021: Meet the Teams!
Last week, the Venture Challenge Summer 2021 kicked off with innovative Life Sciences & Health startups participating in the first bootcamp. The participating teams worked on shaping their value propositions, vision and competitive differentiation to translate their idea into a solid business case.
Light at the End of the Tunnel
"It is unprecedented how the global life sciences community has been able to discover and develop solutions to one of the biggest challenges we are facing, the ongoing pandemic", says Hans Schikan, Special Envoy Vaccines and Top Team member Top Sector LSH, Health~Holland.
Health~Holland Dient met Unieke Coalitie Biotech Booster Groeifondsaanvraag in
Heuglijk nieuws! Health~Holland heeft deze week samen met HollandBIO, alle universiteiten, UMC’s, een hele trits hogescholen en met de support van diverse topsectoren, VC’s en brancheorganisaties, een Groeiplan ingediend waarin ze de krachten bundelen om biotech een boost te geven.
€8.5M Investment Accelerates Availability of Integrated Photonic Biosensing for Early Diagnostics
LioniX International biosensing partner Surfix BV announces an investment of € 8,5 million by a Dutch consortium consisting of companies Qurin Diagnostics BV and LioniX International, industry accelerator PhotonDelta and the East Netherlands Development Agency Oost NL for further development of Surfix’s plug-and-play diagnostics platform.
NTrans Technologies closes Series A Investment to Accelerate Development of Gene Editing Therapy
NTrans Technologies (NTrans), a leader in gene editing technologies, announced a Series A investment of 2 million Euros, led by Essential Investments, together with BOP Capital, Utrecht Health Seed Fund, and Starfish Innovations. Through this investment, NTrans aims to advance the development of its gene editing-based therapy for Duchenne Muscular Dystrophy (DMD).
MIMETAS Opens Phenotypic Screening Center
MIMETAS, the global leader in human-relevant organ-on-a-chip models, has just opened their Phenotypic Screening Center. The center facilitates large-scale screening campaigns on Organ-on-a-Chip models, a powerful technology that improves the human physiological relevance of cultured tissues by utilising microfluidic techniques.
Met Evenwichtige Afspraken Komen Startups Beter uit de Startblokken
Het kabinet wil jonge ondernemers en universiteiten met elkaar aan tafel brengen om tot evenwichtigere afspraken bij het starten van een bedrijf te komen. Dat is hard nodig, want uit een recent AWTI-advies blijkt dat academische startups nog te vaak het onderspit delven bij onderhandelingen met universiteiten.